β-Cyclodextrin with Sodium Alginate based Nanosponges Preparation and Characterization in the Removal of Organic Toxin: p-Cresol in the Simulated Biological Fluids
-
Published:2022-11-22
Issue:
Volume:
Page:261-271
-
ISSN:2231-5659
-
Container-title:Asian Journal of Research in Pharmaceutical Sciences
-
language:en
-
Short-container-title:AJPS
Author:
Abdul Azeez Syed1, Sultana Afreen1, Hajera Amtul1
Affiliation:
1. Department of Pharmaceutics, Deccan School of Pharmacy, Affiliated to Osmania University, Dar-Us-Salam, Aghapura, Hyderabad - 500001, Telangana-India.
Abstract
Sodium alginate (SA)-based β-cyclodextrin(β-CD) can show an amazing adsorption capacity and are considered as secure and biocompatible frameworks for evacuating harmful particles from the body. Tyrosine, an amino acid which is found in certain nourishment and food constituents is changed over into p-Cresyl sulfate by intestine microbiota and on the off chance that this cannot be evacuated from the body, it will come-up as a dangerous uremic toxin in the body and rapid removal of this toxic molecule is relevant especially for patients affected by chronic kidney disease. Based on the necessity in the removal of this protein bound uremic toxin, Innovative cyclodextrin polymers were synthesized with different concentrations of sodium alginate to form nanosponges which are able to remove p-Cresol (Phenolic molecule), before it converted into the toxic form i,e,. p-Cresyl sulfate in the body. Furthermore, in vitro studies were carried out using optimal concentrations of sodium alginate with β-cyclodextrin-NS formulations by assessing physicochemical properties, stability, phenol adsorption capacity and in vitro toxicity. Nanosponges (NSs) were found to be of 1:2 proportion of β-cyclodextrin with sodium alginate respectively as NS2-formulation with an adsorption efficiency of in-vitro phenol toxin is 72%. In contrast, this subsidiary was more-steady in gastrointestinal media. In conclusion, this idea proposes that CD-NS details are secure and successful in expelling harmful atoms from the body. Their potential utilization in veterinary or human medication may diminish dialysis recurrence and lead to decreased phenol arrangement which concurrently decreases the cardiovascular and renal burden.
Publisher
A and V Publications
Reference56 articles.
1. Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E., Hsu, C.-Y., 2004. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N. Engl. J. Med. 351, 1296–1305. 2. Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O’Callaghan, C.A., Lasserson, D.S Hobbs, F.D.R., 2016. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS ONE 11, e0158765. 3. Perlman, R.L., Finkelstein, F.O., Liu, L., Roys, E., Kiser, M., Eisele, G., Burrows-Hudson, S., Messana, J.M., Levin, N., Rajagopalan, S., Port, F.K., Wolfe, R.A., Saran, R., 2005. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am. J. Kidney Dis. 45, 658–666. 4. GBD, 2017. Causes of Death Collaborators, 2018. Global, regional, and national age-sex- specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 392, 1736–1788. 5. Kuehn BM. Excess Deaths From End-Stage Kidney Disease Early in Pandemic. JAMA. 2021;326(4):300.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|